FDMT Competitors & Alternatives
Compare 4D Molecular Therapeutics Inc with similar stocks in the same industry
Biotechnology
FDMT
Main Stock$15.83
Tradestie Score
34
Market Cap
$407.71M
Revenue Growth
251.1%
Analyst Upside
+83.8%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCS
Oculis Holding AG Ordinary shares
|
$13.09
|
$910.64M | - | 39 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$23.90
|
$906.29M | - | 52 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$43.55
|
$903.54M | - | 34 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$107.96
|
$900.91M | - | 34 | Compare |
|
GERN
Geron Corp
|
$1.52
|
$899.60M | - | 42 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$57.74
|
$894.30M | - | 48 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$23.88
|
$887.30M | - | 49 | Compare |
|
ANL
ANL
|
$13.70
|
$883.54M | - | 39 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$5.21
|
$879.90M | 6.0 | 39 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$8.87
|
$871.90M | - | 65 | Compare |
More FDMT Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2836)
238 stocks in this industry